In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Alternative Credential Segment | 353.4 | 287.9 | 157.5 | 63.4 | 16.3 | | | |
Degree Program Segment | 592.3 | 486.7 | 417.2 | 348.4 | | | | |
Other | | | | | 270.4 | | | |
Total revenues | 945.7 | 774.5 | 574.7 | 411.8 | 286.8 | 205.9 | 150.2 | 110.2 |
Revenue growth [+] | 22.1% | 34.8% | 39.6% | 43.6% | 39.3% | 37.1% | 36.2% | 32.6% |
Alternative Credential Segment | 22.8% | 82.8% | 148.3% | 288.5% | | | | |
Degree Program Segment | 21.7% | 16.7% | 19.8% | | | | | |
Graduate Program | | | | | 31.4% | 37.1% | | |
Cost of goods sold | 247.0 | 235.2 | 162.9 | 92.2 | 58.2 | 41.0 | 27.2 | 22.6 |
Gross profit | 698.6 | 539.3 | 411.8 | 319.6 | 228.5 | 164.9 | 123.0 | 87.6 |
Gross margin | 73.9% | 69.6% | 71.7% | 77.6% | 79.7% | 80.1% | 81.9% | 79.5% |
Selling, general and administrative [+] | 664.7 | 563.7 | 473.4 | 304.0 | 213.6 | 152.6 | 117.0 | 88.6 |
Sales and marketing | 456.1 | 390.2 | 342.4 | 221.0 | 150.9 | 106.6 | 82.9 | 65.2 |
General and administrative | 208.6 | 173.5 | 131.0 | 83.0 | 62.7 | 46.0 | 34.1 | 23.4 |
Research and development | 179.1 | 155.9 | 115.5 | 63.8 | 45.9 | 33.3 | | |
Other operating expenses | 22.3 | -1.4 | -0.7 | -1.7 | -0.9 | | 32.0 | 26.9 |
Adjusted EBITDA | 38.8 | -0.4 | -55.0 | 17.7 | 11.4 | 4.5 | -6.4 | -14.8 |
Adjusted EBITDA margin | 4.1% | -0.1% | -9.6% | 4.3% | 4.0% | 2.2% | -4.2% | -13.4% |
Stock-based compensation | 97.8 | 82.0 | 51.5 | 31.4 | 21.9 | 15.8 | 12.5 | 7.5 |
EBITDA [+] | -59.0 | -82.5 | -106.5 | -13.8 | -10.5 | -11.3 | -18.9 | -22.3 |
EBITDA growth | -28.5% | -22.6% | 674.5% | 30.8% | -6.8% | -40.2% | -15.4% | -5.8% |
EBITDA margin | -6.2% | -10.6% | -18.5% | -3.3% | -3.7% | -5.5% | -12.6% | -20.2% |
Depreciation | 12.5 | 13.4 | 11.5 | 8.9 | 5.6 | 1.8 | 1.1 | 5.6 |
EBITA | -71.5 | -95.8 | -118.1 | -22.6 | -16.1 | -13.0 | -20.0 | -27.9 |
EBITA margin | -7.6% | -12.4% | -20.5% | -5.5% | -5.6% | -6.3% | -13.3% | -25.3% |
Amortization of intangibles | 95.9 | 83.1 | 58.3 | 23.9 | 14.0 | 8.0 | 6.1 | |
EBIT [+] | -167.4 | -178.9 | -176.4 | -46.5 | -30.1 | -21.0 | -26.1 | -27.9 |
EBIT growth | -6.4% | 1.5% | 279.0% | 54.4% | 43.3% | -19.4% | -6.4% | -0.5% |
EBIT margin | -17.7% | -23.1% | -30.7% | -11.3% | -10.5% | -10.2% | -17.4% | -25.3% |
Non-recurring items [+] | | | 70.4 | | | | | |
Asset impairment | | | 70.4 | | | | | |
Interest expense, net [+] | 49.7 | 26.0 | 7.6 | -5.1 | -0.3 | -0.3 | 0.4 | 1.1 |
Interest expense | 51.2 | 27.3 | 13.4 | 0.1 | 0.1 | 0.0 | 0.6 | 1.2 |
Interest income | 1.5 | 1.4 | 5.8 | 5.2 | 0.4 | 0.4 | 0.2 | 0.1 |
Other income (expense), net [+] | 21.2 | -13.1 | -0.7 | -1.7 | -0.9 | | -0.3 | |
Gain (loss) on debt retirement | -1.1 | -11.7 | | | | | | |
Other | | | | | | | | -1.1 |
Pre-tax income | -196.0 | -218.0 | -255.1 | -43.2 | -30.7 | -20.7 | -26.7 | -29.0 |
Income taxes | -1.2 | -1.5 | -19.9 | -4.9 | -1.3 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.6% | 0.7% | 7.8% | 11.3% | 4.2% | 0.0% | 0.0% | 0.0% |
Net income | -194.8 | -216.5 | -235.2 | -38.3 | -29.4 | -20.7 | -26.7 | -29.0 |
Net margin | -20.6% | -28.0% | -40.9% | -9.3% | -10.3% | -10.0% | -17.8% | -26.3% |
|
Basic EPS [+] | ($2.61) | ($3.22) | ($3.83) | ($0.69) | ($0.60) | ($0.44) | ($0.63) | ($0.90) |
Growth | -19.0% | -15.8% | 458.1% | 14.5% | 35.1% | -29.6% | -30.3% | -76.3% |
Diluted EPS [+] | ($2.61) | ($3.22) | ($3.83) | ($0.69) | ($0.60) | ($0.44) | ($0.63) | ($0.90) |
Growth | -19.0% | -15.8% | 458.1% | 14.5% | 35.1% | -29.6% | -30.3% | -76.3% |
|
Shares outstanding (basic) [+] | 74.6 | 67.1 | 61.4 | 55.8 | 49.1 | 46.6 | 42.4 | 32.1 |
Growth | 11.1% | 9.4% | 10.0% | 13.8% | 5.3% | 9.9% | 32.3% | 331.6% |
Shares outstanding (diluted) [+] | 74.6 | 67.1 | 61.4 | 55.8 | 49.1 | 46.6 | 42.4 | 32.1 |
Growth | 11.1% | 9.4% | 10.0% | 13.8% | 5.3% | 9.9% | 32.3% | 331.6% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |